1
Mansuri Muzammil M, Martin John C, Hudyma Thomas W: Carbocyclic nucleosides and nucleotides.. Squibb Bristol Myers Co, May 23, 1990: EP0369409-A1 (54 worldwide citation)

The invention relates to 1-B-4-phosphonylmethoxycyclopentane compounds having Formula I or Formula II wherein R and R are independently hydrogen, hydroxy, chlorine, bromine, or an organic substituent having 1 to 5 carbon atoms and selected from carbacyloxy, alkoxy, alkylthio, amino, alkylamino and d ...


2
Hudyma Thomas W, Zheng Xiaofan, He Feng, Ding Min, Bergstrom Carl P, Hewawasam Piyasena, Martin Scott W, Gentles Robert G: Inhibitors of hcv replication. Bristol Myers Squibb Company, Hudyma Thomas W, Zheng Xiaofan, He Feng, Ding Min, Bergstrom Carl P, Hewawasam Piyasena, Martin Scott W, Gentles Robert G, EPPERSON James, February 23, 2006: WO/2006/020082 (48 worldwide citation)

Indole compounds of Formula (I) are described. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV. Different forms and compositions comprising the compounds are also described as well as methods of preparing the compounds.


3
Hudyma Thomas W, Zheng Xiaofan, He Feng, Ding Min, Bergstrom Carl P, Hewawasam Piyasena, Martin Scott W, Gentles Robert G: Inhibitors of hcv replication. Bristol Myers Squibb Company, Hudyma Thomas W, Zheng Xiaofan, He Feng, Ding Min, Bergstrom Carl P, Hewawasam Piyasena, Martin Scott W, Gentles Robert G, EPPERSON James, August 16, 2007: WO/2007/092000 (24 worldwide citation)

Indole compounds of Formula I are described. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV. Different forms and compositions comprising the compounds are also described as well as methods of preparing the compounds. (I)


4
Kaplan Murray A, Hudyma Thomas W, Lipper Robert A: Sels de cephalosporine et compositions injectables. Bristol Myers Co, February 6, 1987: FR2585705-A1 (7 worldwide citation)

LES SELS D'ADDITION CRISTALLINS DES ACIDES SULFURIQUE, DINITRIQUE, MONOCHLORHYDRATE, DICHLORHYDRATE ET LES DI- ET SESQUI-ORTHOPHOSPHATE DU 7-A-(AMINOTHIAZOL-4-YL)-A-(Z)-METHOXYIMINOACETAMIDO-3 - (1-METHYL-1-PYRROLIDINIO)METHYL -3-CEPHEM-4-CARBOXYLATE SONT STABLES MEMES A DES TEMPERATURES ELEVEES. ON ...


5
Meanwell Nicholas A, Gentles Robert G, Ding Min, Bender John A, Kadow John F, Hewawasam Piyasena, Hudyma Thomas W, Zheng Xiaofan: Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors. Bristol Myers Squibb Company, Meanwell Nicholas A, Gentles Robert G, Ding Min, Bender John A, Kadow John F, Hewawasam Piyasena, Hudyma Thomas W, Zheng Xiaofan, EPPERSON James, March 22, 2007: WO/2007/033032 (7 worldwide citation)

The invention encompasses compounds of formula (I), pharmaceutically acceptable salts thereof, compositions, and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.


6
Kaplan Murray Arthur, Hudyma Thomas W, Lipper Robert Alan: Cephalosporin salts and injectable compositions. Bristol Myers Co, March 18, 1987: GB2179936-A (3 worldwide citation)

LES SELS D'ADDITION CRISTALLINS DES ACIDES SULFURIQUE, DINITRIQUE, MONOCHLORHYDRATE, DICHLORHYDRATE ET LES DI- ET SESQUI-ORTHOPHOSPHATE DU 7-A-(AMINOTHIAZOL-4-YL)-A-(Z)-METHOXYIMINOACETAMIDO-3 - (1-METHYL-1-PYRROLIDINIO)METHYL -3-CEPHEM-4-CARBOXYLATE SONT STABLES MEMES A DES TEMPERATURES ELEVEES. ON ...


7

8

9
Bergstrom Carl P, Martin Scott W, Hudyma Thomas W: Hcv ns5b inhibitors. Bristol Myers Squibb Company, Bergstrom Carl P, Martin Scott W, Hudyma Thomas W, EPPERSON James, August 16, 2007: WO/2007/092888 (3 worldwide citation)

The invention encompasses compounds of Formula (I) as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.


10
Gentles Robert G, Zheng Xiaofan, Ding Min, Tu Yong, Han Ying, Hewawasam Piyasena, Kadow John F, Bender John A, Yeung Kap Sun, Grant Young Katharine A, Hudyma Thomas W: Compounds for the treatment of hepatitis c. Bristol Myers Squibb Company, Gentles Robert G, Zheng Xiaofan, Ding Min, Tu Yong, Han Ying, Hewawasam Piyasena, Kadow John F, Bender John A, Yeung Kap Sun, Grant Young Katharine A, Hudyma Thomas W, EPPERSON James, September 18, 2008: WO/2008/112473 (3 worldwide citation)

The invention encompasses compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using. these compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.